Website profile

Healiotwo

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.

  • 299articles · 30d
  • 1+ day agolatest article
  • Aug 14, 2026earliest in window
  • 75%with images
  • 84avg words
articles per day
Categories
  • Medical 294
  • Health 292
  • Health & Wellness 272
  • Beauty & Fitness 6
  • Food & Drink 4
  • Law & Government 3
  • Science & Technology 3
  • Sensitive Subjects 3

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

healiotwo
healio.com > resources > dermintel-psoriasis > expert-videos-on-psoriasis > incredibly-important-expanded-approvals-in-pediatric-psoriasis

‘Incredibly important’ expanded approvals in pediatric psoriasis

1+ week, 3+ day ago   (186+ words) Dive Deeper by Asking What treatment options are available to pediatric patients with psoriasis? Experts: Eingun James Song, MD Video Released: September 2, 2026 In this video, Eingun James Song, MD, FAAD, discusses two recently expanded approvals of psoriasis treatments in pediatric…...

healio.com
healio.com > news > rheumatology > 20/26/0831 > opioid-use-disorder-relatively-common-in-patients-with-rheumatic-diseases

Opioid use disorder ‘relatively common’ in rheumatic disease

1+ week, 4+ day ago   (63+ words) Although opioid use disorder is “relatively common” in rheumatology settings, fewer than 15% of patients with this disorder and rheumatic disease receive medications to treat it, according to data published in Arthritis Care & Research.“Patients with rheumatic…...

healiotwo
healio.com > news > rheumatology > 20/26/0828 > deucravacitinib-shows-superior-efficacy-in-psoriatic-arthritis-at-52-weeks

Deucravacitinib shows ‘superior efficacy’ in psoriatic arthritis at 52 weeks

1+ week, 5+ day ago   (58+ words) Deucravacitinib demonstrated “superior efficacy” and tolerability vs. placebo at 16 weeks, and sustained efficacy through 52 weeks, in adults with active psoriatic arthritis, according to data published in Arthritis & Rheumatology. Philip J. Mease, MD, of Swedish Medical Center and the…...

healiotwo
healio.com > news > dermatology > 20/26/0819 > comprehensive-psoriasis-care-must-include-cardiometabolic-mental-health-screenings

‘Comprehensive psoriasis care’ must include cardiometabolic, mental health screenings

3+ week, 3+ day ago   (409+ words) Psoriasis Action Month marks a time to raise awareness about a systemic inflammatory disease with effects that extend far beyond the skin.“Despite the skin being the most visible manifestation of this condition, psoriasis is more than a skin…...

healio.com
healio.com > news > orthopedics > 20/26/0814 > patellar-tendonlateral-trochlear-ridge-distance-may-predict-patellofemoral-instability

PT-LTR distance may predict patellar instability

4+ week, 1+ day ago   (50+ words) PHOENIX — Results presented at the Arthroscopy Association of North America Annual Meeting showed patellar tendon-lateral trochlear ridge distance may be a reliable measurement for predicting patellofemoral instability.“[Patellar tendon-lateral trochlear ridge] distance demonstrated higher sensitivity than [tibial tubercle-trochlear…...